Anemia drugs News
Most Popular Anemia drugs Story
2. Epogen/Aranesp - Top 10 Warnings and Recalls
Drug: Epogen/Aranesp 2006 sales: 4.1 B/$2.5 B Manufacturer: Amgen Safety concern: “black box;†heart and vascular problems at higher doses Related Articles: > Analyst: Anemia drug warnings Read more...
Latest Headlines
- July 5, 2011
- June 27, 2011
- June 17, 2011
- January 20, 2011
- October 19, 2010
- October 15, 2010
- September 24, 2010
- July 28, 2010
- July 27, 2010
- June 17, 2010
- January 7, 2010
- November 2, 2009
- August 26, 2009
- August 21, 2009
- September 18, 2008
- August 28, 2008
- July 31, 2008
- November 29, 2007
- October 19, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
